Clinical Trial Update: Pentoxifylline Dose Optimization in Neonatal Sepsis [Phase 3]

View source ↗

Summary

Phase 3 trial update on dose optimization of pentoxifylline for neonatal late-onset sepsis; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Late-onset Sepsis

Drugs mentioned

• Pentoxifylline (pentoxifylline)

Snippet

Sponsor: Erasmus Medical Center | Conditions: Neonatal Late Onset Sepsis | Phase 3 | Status: COMPLETED